1,000+ Opportunities
Find the right grant
Search federal, foundation, and corporate grants with AI — or browse by agency, topic, and state.
Agentic AI-EnableD CardioVascular CAre TransfOrmation (ADVOCATE) is sponsored by Advanced Research Projects Agency for Health (ARPA-H). A competitive Innovative Solutions Opening (ISO) seeking teams to develop trusted, autonomous clinical AI agents for continuous cardiovascular patient care and monitoring.
Get a weekly digest of new grants like this
A free weekly digest of new foundation and federal funding opportunities as they're added to Granted. Unsubscribe anytime.
Or search similar grants →According to the current listing, eligibility includes: Innovators from technology, academia, and small business sectors; must develop a patient-facing AI agent, supervisory monitoring system, and integration strategy. Confirm the full requirements in the official notice before applying.
The current listing shows $1,000,000 - $9,000,000. Verify award ceilings, matching requirements, and allowable costs in the official notice.
The published deadline was February 27, 2026, which has passed. Check the official notice for any future application windows before investing time in a proposal.
Agentic AI-EnableD CardioVascular CAre TransfOrmation (ADVOCATE) is funded by Advanced Research Projects Agency for Health (ARPA-H). Verify program details on the funder's official page before applying.
Yes — this listing is flagged as national in scope, so applicants across the U.S. may apply, subject to the sponsor's other eligibility criteria.
Applications go through the funder's official portal — the Apply Now link on this page goes there directly.
The Emerging Health Innovators solicitation drops on SAM.gov by the end of September 2026 with 16 named topic areas, an eight-year terminal-degree ceiling, and an eligibility screen that bars national labs, FFRDCs, UARCs, and anyone who has ever led an ARPA prime award. Proposers' Day is October 13. Here is how to read the design.
Read articleARPA-H's 2026 SBIR/STTR BAA opens seven transformative health topics with $600K Phase I and $3.5M Phase II contracts — non-dilutive, milestone-driven money. The July 10 Solution Summary gate decides who ever gets to pitch. Here's how the ARPA-H model differs from NIH and how small health-tech firms actually get through the funnel.
Read articleARPA-H's FY2026 SBIR/STTR solicitation closes its Solution Summary stage July 10, with seven named topics spanning women's health, autoimmune diagnostics, toxin removal, and neurosurgical robotics. Awards run up to $600K for Phase I and $3.5M for Phase II — but they are contracts, not grants, and the four-to-six-page summary is the gate that filters out most applicants. Here is how ARPA-H's model actually works and how to win the first stage.
Read article